J Menopausal Med.  2016 Dec;22(3):131-138. 10.6118/jmm.2016.22.3.131.

The Impact of Inflammatory and Infectious Diseases of Vulvar on Quality of Life

• Kelekçi K
• Özyurt S
• Özkan B
• Karaca S
• Karakuzu A
• Bilgin I

• KMID: 2378232
• DOI: http://doi.org/10.6118/jmm.2016.22.3.131

Abstract

OBJECTIVES
This study aimed to evaluate the effects of vulvar dermatoses (VD) and vulvar infections (VE) on anxiety, depression scores, general, and dermatological quality of life (QOL) of women.
METHODS
We conducted a cross-sectional survey on patients diagnosed with VD and VE. All patients were assessed using a sociodemographic form, Skindex-29 scale, World Health Organization QOL (WHOQOL) BREF scale, Hamilton anxiety rating scale (HAM-A), Hamilton depression rating scale (HAM-D).
RESULTS
HAM-A score was significantly higher in the VD group than in the control group. Based on age groups, all subscales of Skindex-29 were found to be higher in women > 50 years. For women with severe pruritus, the symptom subscale was higher in patients with skin involvement and the function and emotion subscales were higher in patients with and emotion subscales were higher in patients with mucosal involvement.
CONCLUSIONS
We found that VD was particularly significantly associated with decreased QOL.

Keyword

Communicable diseases; Inflammation; Quality of life; Vulva; Women's health

MeSH Terms

Anxiety
Communicable Diseases*
Cross-Sectional Studies
Depression
Female
Humans
Inflammation
Pruritus
Quality of Life*
Skin
Skin Diseases
Vulva
Women's Health
World Health Organization

Reference

1. Barchino-Ortiz L, Suárez-Fernández R, Lázaro-Ochaita P. Vulvar inflammatory dermatoses. Actas Dermosifiliogr. 2012; 103:260–275.

2. Stewart KAM. Vulvar dermatoses: A practical approach to evaluation and management. J Clin Outcomes Manag. 2012; 19:205–220.

3. Nappi RE, Palacios S. Impact of vulvovaginal atrophy on sexual health and quality of life at postmenopause. Climacteric. 2014; 17:3–9.

4. Simpson RC, Thomas KS, Murphy R. Outcome measures for vulval skin conditions: a systematic review of randomized controlled trials. Br J Dermatol. 2013; 169:494–501.

5. Hussain SH, Sterling J. Skin diseases affecting the vulva. Obstet Gynaecol Reprod Med. 2014; 24:141–147.

6. Krapf JM, Goldstein A. The vulvar dermatoses: Part of the differential diagnosis for sexual dysfunction. The Female Patient. 2012; 37:28–30. 32–34.

7. Chren MM. The Skindex instruments to measure the effects of skin disease on quality of life. Dermatol Clin. 2012; 30:231–236. xiii

8. Both H, Essink-Bot ML, Busschbach J, Nijsten T. Critical review of generic and dermatology-specific health-related quality of life instruments. J Invest Dermatol. 2007; 127:2726–2739.

9. Yamaguchi K, Suganuma N, Ohashi K. Quality of life evaluation in Japanese pregnant women with striae gravidarum: a cross-sectional study. BMC Res Notes. 2012; 5:450.

10. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983; 67:361–370.

11. Aydemir Ö, Güvenir T, Küey L, Kültür S. Validity and reliability of Turkish version of hospital anxiety and depression scale. Turk J Psychiatry. 1997; 8:280–287.

12. Skevington SM, Lotfy M, O'Connell KA. The World Health Organization's WHOQOL-BREF quality of life assessment: psychometric properties and results of the international field trial. A report from the WHOQOL group. Qual Life Res. 2004; 13:299–310.

13. Blay SL, Marchesoni MS. Association among physical, psychiatric and socioeconomic conditions and WHOQOLBref scores. Cad Saude Publica. 2011; 27:677–686.

14. Hsiung PC, Fang CT, Chang YY, Chen MY, Wang JD. Comparison of WHOQOL-bREF and SF-36 in patients with HIV infection. Qual Life Res. 2005; 14:141–150.

15. Finlay AY. Quality of life assessments in dermatology. Semin Cutan Med Surg. 1998; 17:291–296.

16. Prinsen CA, Lindeboom R, de Korte J. Interpretation of Skindex-29 scores: cutoffs for mild, moderate, and severe impairment of health-related quality of life. J Invest Dermatol. 2011; 131:1945–1947.

17. Pavlis MB, Rice ZP, Veledar E, Bradley BR, Spraker MK, Chen SC. Quality of life of cutaneous disease in the ectodermal dysplasias. Pediatr Dermatol. 2010; 27:260–265.

18. Choi S, Kim DY, Whang SH, Lee JH, Hann SK, Shin YJ. Quality of life and psychological adaptation of Korean adolescents with vitiligo. J Eur Acad Dermatol Venereol. 2010; 24:524–529.

19. Kim DY, Lee JW, Whang SH, Park YK, Hann SK, Shin YJ. Quality of life for Korean patients with vitiligo: Skindex-29 and its correlation with clinical profiles. J Dermatol. 2009; 36:317–322.

20. Ertürk IE, Arican Ö, Ömürlü IK, Süt N. Effect of the pruritus on the quality of life: a preliminary study. Ann Dermatol. 2012; 24:406–412.

21. Klein R, Moghadam-Kia S, Taylor L, Coley C, Okawa J, LoMonico J, et al. Quality of life in cutaneous lupus erythematosus. J Am Acad Dermatol. 2011; 64:849–858.

22. Hickey S, Bell H. Quality of life in the vulvar clinic: a pilot study. J Low Genit Tract Dis. 2010; 14:225–229.